| Submit your comments on this article |
| Science & Technology |
| Oxitec had ready-to-go lab in Marathon, FL when FDA approved OX513A in March |
| 2016-08-06 |
| Posted by:jefe101 |
| #3 Inovio 2010 gates foundation R&d grant grew to 2013 funding with mvi 2013 Glaxo smith Kline acquires gates funded okairos Both are heavily involved in vaccine development for various African creatures Both are also 1&2 for zika human trials being conducted in the USA right now |
| Posted by: Jefe101 2016-08-06 01:53 |
| #2 In Brasil! |
| Posted by: Jefe101 2016-08-06 01:40 |
| #1 OX513A is engineered to block tetracycline production resulting in its demise. It is estimated up to 75% of tetracycline administered to farm animals is excreted in waste. Oxitec acknowledges tetracycline present in the environment could result in a survival rate of up to 15% of the Ox513A population. |
| Posted by: Jefe101 2016-08-06 01:39 |